Just saw that Rosenblatt initiated coverage on Palantir (PLTR) back in late February with a Buy rating, and the numbers they're laying out are pretty interesting. The average price target sits around $193, which would be roughly 42% upside from where it was trading at that time. That's a decent spread too - forecasts range from $70 to $273, so clearly there's some debate in the room.

What caught my eye though is the institutional positioning. Over 3,700 funds and institutions are holding PLTR, and they've actually been adding to positions. Vanguard's total stock market index fund alone increased its stake by about 2.4%, and they've bumped up allocation by nearly 48% over the quarter. JPMorgan and other major players are doing similar moves.

That said, the put/call ratio is sitting at 1.06, which leans bearish, so not everyone's convinced. Revenue projections show a decline, which is worth keeping an eye on. But when you've got Rosenblatt coming in bullish and the big institutional money quietly accumulating, it's definitely worth paying attention to. The question is whether those Rosenblatt price targets hold up or if we see some profit-taking pressure first.